Crispr Therapeutics shares owned by Lombard Odier Asset Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Lombard Odier Asset Management
from 13F filings
Historical chart of Lombard Odier Asset Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Lombard Odier Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Lombard Odier Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-03-31 | $2.5M | 55k | 45.23 |
| 2022-12-31 | $3.4M | 83k | 40.65 |
| 2022-09-30 | $3.9M | 59k | 65.35 |
| 2022-06-30 | $3.9M | 64k | 60.77 |
| 2022-03-31 | $12M | 191k | 62.77 |
| 2021-12-31 | $14M | 178k | 75.78 |
More positions owned by Lombard Odier Asset Management
View all positions for Lombard Odier Asset Management